Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Transplant Immunology|June 29, 2005
Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseasesI B Resnick, M Y Shapira, S Slavin
Critical Reviews in Oncology/Hematology|February 17, 2007
Allogeneic hematopoietic stem cell transplantation in the elderlyMichael Y Shapira, P Tsirigotis, I B Resnick, et al.
Bone Marrow Transplantation|September 5, 2007
The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantationA Abdul-Hai, L Weiss, D Ergas, et al.
Bone Marrow Transplantation|July 29, 2014
Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimenP D Tsirigotis, I B Resnick, B Avni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donorsM Bitan, R Or, M Y Shapira, et al.
American Journal of Hematology|October 31, 2003
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliteransM Bitan, I B Resnick, R Or, et al.
Bone Marrow Transplantation|November 13, 2007
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemiaM Bitan, R Or, M Y Shapira, et al.
Bone Marrow Transplantation|October 14, 2008
Alefacept treatment for refractory chronic extensive GVHDM Y Shapira, A Abdul-Hai, I B Resnick, et al.
Infection|May 9, 2013
Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patientsD Averbuch, E Horwitz, J Strahilevitz, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Pageof 2